| Literature DB >> 12144734 |
William H Frishman1, Brian D Brosnan, Marc Grossman, Debasish Dasgupta, And Diana K Sun.
Abstract
Cardiovascular disease is common, affecting an increasing number of persons as the population ages. To combat this growing health problem, physicians use a multitude of medications in the treatment of their patients. Although pharmacologic therapy greatly enhances quality of life for a majority of patients, there is always the potential for an unfavorable reaction. For example, cardiovascular drugs can induce a vast array of adverse dermatologic responses. This article reviews the various cutaneous reaction patterns that can occur as a result of treatment with Class I and II antiarrhythmic agents.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12144734 DOI: 10.1097/00045415-200207000-00008
Source DB: PubMed Journal: Cardiol Rev ISSN: 1061-5377 Impact factor: 2.644